Ibex and PathPresenter Partner to Advance AI-powered Digital Pathology Solutions
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to advance the adoption of AI-powered digital pathology.
Read MorePosted by Andy Lundin | Mar 6, 2024 | Digital Pathology |
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to advance the adoption of AI-powered digital pathology.
Read MorePosted by Andy Lundin | Mar 1, 2024 | Prostate |
AI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.
Read MorePosted by Andy Lundin | Feb 29, 2024 | Cancer |
The Riskguard test detects genetic changes that can increase risk for 10 common cancers, using a simple blood or saliva sample.
Read MorePosted by Chris Wolski | Feb 21, 2024 | Lab Automation |
An ever-growing amount of diagnostic data has led to information overload, often making accurate diagnoses more difficult.
Read MorePosted by Andy Lundin | Feb 20, 2024 | Prostate |
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read More